Nanotechnology solution to NAFLD – study reported in Nature Communications
An international team of scientists led by BUnano Center Director Dr. Mark Grinstaff, Dr. Orian Shirihai (UCLA), and BUnano Crossdisciplinary Fellowship Alumna Dr. Jialiu Zeng (Nanyang Technological University, Singapore) reports on a new type of nanotechnology as a potential first-in-kind therapeutic for non-alcoholic fatty liver disease (NAFLD), which affects 20 to 30% of the world’s […]